University of Pennsylvania at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

University of Pennsylvania takes part in 3 sessions at CTAD 2026 in Boston. Its program spans anti-amyloid treatment safety, light and sound stimulation and digital testing in primary care. Its work includes automated MRI measurement of ARIA-E and topline results of the HOPE pivotal study of Spectris.

Organization	CTAD 2026 Attendance
University of Pennsylvania Philadelphia, Pennsylvania
upenn.edu Universities & institutes Runs the Penn Alzheimer's Disease Research Center and Penn Memory Center, and hosts the ADNI biomarker laboratory.	Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Automated FLAIR volumetry of ARIA-E under lecanemab and donanemab: agreement with clinical grading, interval change, and an audit of the manual reference (P073) PET and MRI imaging · Anti-amyloid and anti-tau therapies Talk Mon Nov 16 5:45pm Spectris Treatment in Mild-to-Moderate Alzheimer’s Disease: Topline Results and Secondary Analyses From the HOPE Pivotal Study Other mechanisms and targets Poster Thu Nov 19 7:15am–5:00pm Digital cognitive assessments in primary care: Outcomes from a real-world implementation study (P505) Digital assessment and AI · Real-world data and access

Organization

CTAD 2026 Attendance

University of Pennsylvania

Philadelphia, Pennsylvania

upenn.edu

Universities & institutes

Runs the Penn Alzheimer's Disease Research Center and Penn Memory Center, and hosts the ADNI biomarker laboratory.

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Automated FLAIR volumetry of ARIA-E under lecanemab and donanemab: agreement with clinical grading, interval change, and an audit of the manual reference (P073)

PET and MRI imaging · Anti-amyloid and anti-tau therapies

Talk

Mon Nov 16
5:45pm

Spectris Treatment in Mild-to-Moderate Alzheimer’s Disease: Topline Results and Secondary Analyses From the HOPE Pivotal Study

Other mechanisms and targets

Poster

Thu Nov 19
7:15am–5:00pm

Digital cognitive assessments in primary care: Outcomes from a real-world implementation study (P505)

Digital assessment and AI · Real-world data and access

Instantly find 20 buyers from University of Pennsylvania

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction